Date of dispatch of this notice: 13/12/2018
Expire date: 22/02/2019
External Reference: 2018-233389
TED Reference: 2018/S 243-555399
Contract notice
Information
Published
Contract notice
[NoticeContract]
[Directive201424]
[Section1]: [Ca]
I.1)
[NameAddressContact]
Health Service Executive (HSE)
N/A
Head Office
Naas
Millennium Park
IE
[Contactpoint]:
Joe Heavey
[AddressPhone]:
+353 061482690
[AddressEmail]:
joe.heavey@hse.ie
[AddressFax]:
+353 061464230
[Internets]:
[UrlGeneral]:
http://www.hse.ie
[UrlBuyerprofile]:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/461
I.2)
[JointProcurement]
[JointProcurementCentral]
I.3)
[InfoTendering]
[AddressObtainDocs]:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=139496&B=ETENDERS_SIMPLE[AddressFurtherinfo]
[AsContactsAbove]:
[AddressSendTendersRequest]
[AddressSendTenders]:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=139496&B=ETENDERS_SIMPLE
[AddressSendTendersRequest]
[AddressToAbove]
I.4)
[CaType]
[MaintypePublicbody]
I.5)
[Mainactivity]
[MainactivHealth]
[Section2]: [Object]
II.1)
[QuantityScopeContract]
II.1.1)
[TitleContract]
Improving the Care of Patients - Gestational Diabetes & Diabetic Foot
[Fileref]:
SBIR Challenge - HSE
II.1.2)
[CpvMain]
73300000
-
II.1.3)
[TypeContract]
[Services]
II.1.4)
[DescrShort]
The Challenge Background
Diabetes is a serious global public health issue which has been described as the most challenging health problem in the 21st century. Between 1998 and 2015, there was a significant increase in the prevalence of doctor diagnosed diabetes among adults in Ireland (increasing from 2.2 % in 1998 to 5.2 % in 2015). The prevalence of undiagnosed diabetes in Ireland ranges from 0.9 – 2.8% of the population. People with diabetes are at serious risk of developing microvascular complications which can result in damage to feet, resulting in loss of sensation, damage to the back of the eye which can lead to blindness and damage to kidneys which can result in kidney failure.
This small business Innovation Research (SBIR) competition specifically targets two key unmet needs:
1) Reducing the risk of women developing diabetes following gestational diabetes
2) Screening for diabetic foot disease in all patients with diabetes
Diabetes is a serious global public health issue which has been described as the most challenging health problem in the 21st century. Between 1998 and 2015, there was a significant increase in the prevalence of doctor diagnosed diabetes among adults in Ireland (increasing from 2.2 % in 1998 to 5.2 % in 2015). The prevalence of undiagnosed diabetes in Ireland ranges from 0.9 – 2.8% of the population. People with diabetes are at serious risk of developing microvascular complications which can result in damage to feet, resulting in loss of sensation, damage to the back of the eye which can lead to blindness and damage to kidneys which can result in kidney failure.
This small business Innovation Research (SBIR) competition specifically targets two key unmet needs:
1) Reducing the risk of women developing diabetes following gestational diabetes
2) Screening for diabetic foot disease in all patients with diabetes
II.1.5)
[ValueMagnitudeEstimatedTotal]
[ValueExclVat]: 200000.00
EUR
II.1.6)
[LotsInfo]
[DivisionLots]:
[Yes]
[LotsSubmittedFor]
[LotsAll]
[LotsCombinationPossible]:
Lots 1 & 2
II.2)
[Description]
II.2.1)
[TitleContract]
[LotNumber]:
1
II.2.2)
[CpvAdditional]
73110000
-
73210000
-
73300000
-
II.2.4)
[DescrProcurement]
1) Reducing the risk of women developing diabetes following gestational diabetes
II.2.5)
[AwardCriteria]
[AwardCriteriaDescriptive]
II.2.6)
[ValueMagnitudeEstimated]
[ValueExclVat]: 200000.00
EUR
II.2.7)
[DurationContractFrameworkDps]
[DurationMonths]:
3
[RenewalsSubject]:
[No]
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[Yes]
[OptionsDescr]:
Enterprise Ireland and the HSE are seeking innovative solutions to the challenges listed so therefore will be open to options that offer viable solutions.
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
II.2)
[Description]
II.2.1)
[TitleContract]
[LotNumber]:
3
II.2.2)
[CpvAdditional]
73110000
-
73210000
-
73300000
-
II.2.4)
[DescrProcurement]
Screening for diabetic foot disease in all patients with diabetes
II.2.5)
[AwardCriteria]
[AwardCriteriaDescriptive]
II.2.6)
[ValueMagnitudeEstimated]
[ValueExclVat]: 200000.00
EUR
II.2.7)
[DurationContractFrameworkDps]
[DurationMonths]:
3
[RenewalsSubject]:
[No]
II.2.10)
[VariantsInfo]
[VariantsAccepted]:
[No]
II.2.11)
[OptionsInfo]
[Options]:
[No]
II.2.13)
[EuProgrInfo]
[EuProgrRelated]:
[No]
[Section3]: [InfoLegal]
III.1)
[ConditionsParticip]
III.1.2)
[EconomicFinancialStanding]
[CriteriaSelectionDocs]
III.1.3)
[TechnicalCapacity]
[CriteriaSelectionDocs]
III.2)
[ConditionsContract]
III.2.2)
[OtherConditions]
As stated in the procurement documents
III.2.3)
[StaffResponsible]
[StaffResponsibleIndicate]
[Section4]: [Procedure]
IV.1)
[Description]
IV.1.1)
[TypeProcedure]
[ProctypeOpen]
IV.1.8)
[GpaInfo]
[GpaCovered]
: [Yes]
IV.2)
[InfoAdmin]
IV.2.2)
[LimitReceiptTendersReqPart]
[Date]:
22/02/2019
[Time]:
18:00
IV.2.4)
[LanguagesAllowed]
[Language_EN]
IV.2.6)
[MinTimeMaintain]
[DurationMonths]
: 6
([FromStatedDate])
IV.2.7)
[OpeningConditions]
[Date]:
22/02/2019
[Time]:
18:00
[OpeningPlace]:
The electronic postbox will be opened by at two designated HSE staff after the official closing date for the competition.
[Section6]: [InfoComplement]
VI.1)
[RecurrenceInfo]
[RecurrentProcurement]:
[No]
VI.2)
[InfoEworkflow]
[EpaymentUsed]
VI.4)
[AppealsProcedure]
VI.4.1)
[AppealsBody]
The High Court
Four Courts
Dublin
7
IE